首页 | 本学科首页   官方微博 | 高级检索  
     

应用EP方案治疗复发和难治性非何杰金氏淋巴瘤的临床观察
引用本文:朱学明,于丁,付小玉. 应用EP方案治疗复发和难治性非何杰金氏淋巴瘤的临床观察[J]. 肿瘤防治研究, 1999, 26(1): 63-64
作者姓名:朱学明  于丁  付小玉
作者单位:1 441000 襄樊 湖北襄樊市中医院;
2 湖北省肿瘤医院
摘    要: 本文总结EP方案,即足叶乙甙(VP-16)联合顺铂(PDD)治疗22例复发和难治性非何杰金氏淋巴瘤。全组总缓解率77.3%,其中完全缓解占22.7%(5例),部分缓解占54.6%(12例)。主要毒副反应为胃肠道反应和骨髓抑制,大部分病人均能耐受。认为EP方案是治疗复发和难治性非何杰金氏淋巴瘤的有效方案。

关 键 词:非何杰金淋巴瘤 足叶乙甙 NHL 药物疗法 EP方案

The clinical observations on treatment of relapsed and refractrary NHL with the EP regimes.
Zhu XueMing,Yu Ding,Fu XiaoYu. The clinical observations on treatment of relapsed and refractrary NHL with the EP regimes.[J]. Cancer Research on Prevention and Treatment, 1999, 26(1): 63-64
Authors:Zhu XueMing  Yu Ding  Fu XiaoYu
Abstract:The essay contributed the relapsed and refractiory NHL 22 cases were treated by the EP regimes,Vp-16 PDD.The effection rate is 77 3%.Complete remissin was 22 7% (5 cases).Partical remissin was 54 16%(12 cases).The main loxicities were gastrointestinal loxicities and bone marrow inhibition most of patients were tolerated.In condusion.the EP regimes is effective in the treatment of relapsed refractory NHL.
Keywords:NHL  Vp-16  PDD
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号